Investigators to Explore Potential of LP-300 With Chemo in Never Smokers With Advanced Lung Cancer
Joshua Eric Reuss, MD, discusses the enrollment criteria for the HARMONIC trial, the demonstrated safety and efficacy of LP-300, and potential benefits of the agent for never smokers with advanced non–small cell lung cancer.
Source: onclive.com